PMDD and Suicide: Understanding the Risk, the Science, and What Needs to Change
Premenstrual dysphoric disorder (PMDD) is often described as a severe form of PMS. But that framing doesn’t come close to capturing the reality for many women.
For some, PMDD is not just distressing — it is life-threatening.
Over the past few years, research has become increasingly clear: PMDD is associated with a markedly increased risk of suicidal thoughts, self-harm, and suicide attempts. And yet, this link remains under-recognised in clinical practice.
This blog explores what we now know about PMDD and suicide, why the risk is so high, and how emerging research is beginning to change the way we understand and respond to it.
How common is suicidality in PMDD?
The statistics are stark.
Research consistently shows that:
Around 70% of people with PMDD experience suicidal thoughts
Around 1 in 3 will attempt suicide
Around half engage in self-harm behaviours
More recent UK-based research echoes this, describing PMDD as a condition where “most” individuals experience suicidal ideation, with very high rates of self-harm and attempts.
This is not a marginal risk. It is central to the condition.
And yet many patients go years — often decades — without anyone asking about the cyclical nature of their symptoms.
Why is suicide risk so high in PMDD?
One of the key insights from recent research is that PMDD-related suicidality is not simply “depression that happens to be worse premenstrually.”
It is different in important ways.
The cyclical nature of risk
PMDD symptoms occur in the luteal phase (the two weeks before a period) and then resolve with menstruation.
This creates a repeating pattern:
Severe psychological distress
Followed by relative normality
Then recurrence the following month
This cyclical pattern can be profoundly destabilising. Patients often describe:
Feeling like a different person each month
Losing trust in their own mind
Repeated exposure to crisis states
Clinically, this matters. Suicide risk is not static — it peaks predictably, which creates both risk and opportunity.
Hormone sensitivity, not hormone levels
PMDD is thought to arise from abnormal sensitivity to normal hormonal fluctuations, rather than abnormal hormone levels.
This sensitivity affects neurotransmitter systems involved in mood regulation, including serotonin and GABA.
The result is a rapid shift into states characterised by:
Hopelessness
Emotional overwhelm
Impulsivity
Intense self-criticism
These are all recognised drivers of suicidal thinking.
Psychological models: the IMV framework
A major recent development is the application of the Integrated Motivational–Volitional (IMV) model of suicide to PMDD.
Researchers at the University of the West of Scotland have developed a PMDD-specific adaptation of this model to better understand risk.
The IMV model suggests that suicide risk develops in stages:
Motivational phase: feelings of defeat, entrapment, and hopelessness
Volitional phase: progression to suicidal behaviour
In PMDD, the hormonal cycle appears to trigger and amplify the motivational phase, pushing individuals rapidly into crisis.
Crucially, the new PMDD-adapted model highlights that:
Risk is time-linked to the menstrual cycle
Traditional assessments may miss this pattern
Intervention needs to be anticipatory, not reactive
Why is this still being missed?
Despite the severity, PMDD-related suicidality is often overlooked.
There are several reasons for this.
1. Symptoms are misdiagnosed
Many patients are initially diagnosed with:
Depression
Anxiety
Bipolar disorder
Personality disorders
without anyone recognising the cyclical pattern linked to the menstrual cycle.
2. Mental health services often don’t ask about periods
Patients frequently report years of contact with mental health services without any assessment of hormonal patterns.
This is a major gap.
3. Crisis care is not designed for cyclical conditions
Current systems tend to respond to acute crises (e.g. A&E presentations), but PMDD requires:
Pattern recognition
Preventative planning
Cycle-aware interventions
Without this, patients can fall into a repeated cycle of crisis → discharge → recurrence.
A shift in thinking: from crisis response to prevention
One of the most important developments in this field is the creation of a PMDD-specific suicide prevention model.
This tool, developed by UK researchers, is designed to help clinicians:
Recognise cyclical patterns of suicidality
Identify high-risk phases within the menstrual cycle
Intervene before crisis escalates
Rather than asking “Are you suicidal right now?”, it encourages a different question:
“Does this happen at a particular time each month?”
That single shift has the potential to change outcomes.
What does this mean for patients?
If you experience PMDD and recognise suicidal thoughts as part of your cycle, there are a few key things to know.
First, this is not a personal failing. It is a recognised, biological pattern.
Second, the predictability of PMDD can be used to your advantage. With the right support, it is possible to:
Identify high-risk windows
Put protective strategies in place in advance
Reduce the intensity and impact of symptoms
Third, effective treatment exists — but it needs to be individualised and often multi-layered, combining hormonal, psychological, and lifestyle approaches.
When to seek urgent help
If you are experiencing suicidal thoughts and feel at risk of acting on them, it is important to seek immediate support:
Contact your GP or NHS 111
Attend A&E
Call Samaritans (116 123 in the UK)
If you are in immediate danger, call 999.
Final thoughts
PMDD is not just about mood swings before a period. For many women, it is a condition that brings them repeatedly to the edge of crisis.
The emerging research is clear: suicide risk in PMDD is high, predictable, and often missed.
But it is also understandable — and increasingly, preventable.
Recognising the pattern is the first step.
How Sirona Health can help
At Sirona Health, consultations are designed to look beyond symptoms in isolation and understand how your hormonal cycle, mental health, and life context interact.
If you are struggling with cyclical mood changes, PMDD, or feeling stuck despite previous treatment, this is a space to explore what is happening in depth and build a plan that actually fits you.
Appointments are available online across the UK and in person at Calcot & Spa near Tetbury.
FAQ
-
Yes. Research shows very high rates of suicidal thoughts, self-harm, and suicide attempts compared to the general population.
-
It appears to relate to brain sensitivity to hormonal changes, which can trigger intense emotional and cognitive shifts during the luteal phase.
-
Often, yes. Many people notice symptoms occur at the same point in their cycle each month.
-
Yes. Treatment may include SSRIs, hormonal therapies, and psychological approaches, tailored to the individual.